Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 444

Results For "EU"

4482 News Found

NPPA brings 80 plus medicines under price regulation
News | March 22, 2021

NPPA brings 80 plus medicines under price regulation

NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.


Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
News | March 18, 2021

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.


Merck brings new renewable energy to the grid through VPPA with Enel Green Power
News | March 18, 2021

Merck brings new renewable energy to the grid through VPPA with Enel Green Power

Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power


LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants
News | March 17, 2021

LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants

Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.


Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO
News | March 15, 2021

Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO

The vaccine was 85 percent effective in preventing severe disease across all regions.


Govt. receives 215 applications for the 36 products under PLI scheme
News | March 13, 2021

Govt. receives 215 applications for the 36 products under PLI scheme

174 applications were received for 23 eligible products under Target Segment IV - Other Chemical Synthesis Based KSMs/ Drug Intermediates/APIs.


Altimmune expands AdCOVID manufacturing collaboration with Lonza
News | March 13, 2021

Altimmune expands AdCOVID manufacturing collaboration with Lonza

AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.


NATCO receives approval for Everolimus tablets for the US market
News | March 09, 2021

NATCO receives approval for Everolimus tablets for the US market

NATCO's partner BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks.


Vivimed Labs receives products approvals from Uzbekistan
News | March 09, 2021

Vivimed Labs receives products approvals from Uzbekistan

Vivimed strategy is to increase its share of Branded products in CIS Markets.


Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder
News | March 08, 2021

Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder

Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.